We need your feedback! Please take 2mins to tell us what you think & suggest future topics
We asked you in January to update to v4.7.2. After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.
To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number.
To update to the latest release:
On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.
On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.
Welcome to the February 2025 update from the RDS team
A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:
The release will also incorporate a number of small fixes, including:
We will let you know when the date and time for the new release are confirmed.
There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.
The Benzodiazepine tapering tool (https://rightdecisions.scot.nhs.uk/benzotapering) is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.
Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.
At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .
We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.
Some important toolkits in development by the RDS team include:
The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.
To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)
To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form - also available in End-user and Provider sections of the RDS Learning and Support area. If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.
With kind regards
Right Decision Service team
Healthcare Improvement Scotland
Feedback should be provided directly within the Renal App.
Additional feedback should be via: ggc.renalservices@nhs.scot
Co-leads of Renal App Group:
Dr Mark Findlay, Consultant Nephrologist, Queen Elizabeth University Hospital Glasgow
Dr Jamie Traynor, Consultant Nephrologist, Queen Elizabeth University Hospital Glasgow
The content in this toolkit has been developed by clinical leads or nominated team members throughout the multidisciplinary team of the Glasgow Renal and Transplant Unit. Specific authorship is provided in each document where relevant.
Appropriateness, relevance and update of content remains with the following leads for each section:
Home Therapies: Dr Emily McQuarrie
CKD: Nurse Diane Wright
Renal Dietary Advice: Ms Angela Doherty
Content has been reviewed and approved by clinical leads or nominated team members throughout the multidisciplinary team of the Glasgow Renal and Transplant Unit. The conceptualization of a patient facing app was supported by the Renal/CIC Clinical Governance Group.
Final content was signed off by Renal App Leads, Drs Findlay and Traynor.
The content will be considered for update 3 years from publication. Any minor updates brought to the attention will be dealt with on an "as needed" basis.
Content updates on the Right Decisions platform will be carried out by the Renal App team, with support from the Right Decision Service team when required.
All documents contained within this App are original work of the Glasgow Renal and Transplant unit.
There are multiple links to external sites. Copyright and responsibility of content remains with those sites.
All icons are from Flaticon.com, accessed through the licence held Tactuum Ltd for the resources supported by the software platform it provides.
The generic email for the Glasgow Renal and Transplant unit is available in the "Contacts" section above and can be used to highlight any feedback or complaints.
Any messages received through the RDS Feedback form will also be forwarded to the App Leads.
The App Leads will address the feedback with involvement of the wider multidisciplinary team where relevant.
The toolkit was user tested by the group of clinicians and people with lived experience in the guideline development group throughout its development.